149 related articles for article (PubMed ID: 3578325)
1. An overview of the pharmacology of intravenously administered ciprofloxacin.
Drusano GL
Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
[TBL] [Abstract][Full Text] [Related]
3. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
Drusano GL; Weir M; Forrest A; Plaisance K; Emm T; Standiford HC
Antimicrob Agents Chemother; 1987 Jun; 31(6):860-4. PubMed ID: 3619418
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
[TBL] [Abstract][Full Text] [Related]
6. A new trifluorinated quinolone: Ro 23-6240 (AM 833).
Weidekamm E; Stöckel K; Dell D
Drugs Exp Clin Res; 1987; 13(2):85-90. PubMed ID: 3107959
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients.
Guay DR; Awni WM; Peterson PK; Obaid S; Breitenbucher R; Matzke GR
Am J Med; 1987 Apr; 82(4A):124-9. PubMed ID: 3578321
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ofloxacin. An overview.
Flor S
Am J Med; 1989 Dec; 87(6C):24S-30S. PubMed ID: 2603892
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics in the elderly. Studies on ciprofloxacin.
Lebel M; Bergeron MG
Am J Med; 1987 Apr; 82(4A):108-14. PubMed ID: 3555025
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function, prediction of multiple-dose kinetics.
Brogard JM; Comte F; Madon M; Spach MO
Eur J Rheumatol Inflamm; 1982; 5(2):113-23. PubMed ID: 7084275
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of meropenem.
Drusano GL; Hutchison M
Scand J Infect Dis Suppl; 1995; 96():11-6. PubMed ID: 7652497
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of fleroxacin in renal impairment.
Weidekamm E
Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
[TBL] [Abstract][Full Text] [Related]
13. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
Alestig K
Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
[TBL] [Abstract][Full Text] [Related]
15. [The role of ciprofloxacine metabolites in its biliary and urinary elimination in man].
Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):719-23. PubMed ID: 3054754
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic model.
Dudley MN; Mandler HD; Gilbert D; Ericson J; Mayer KH; Zinner SH
Am J Med; 1987 Apr; 82(4A):363-8. PubMed ID: 3555061
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of nicotine in kidney failure.
Molander L; Hansson A; Lunell E; Alainentalo L; Hoffmann M; Larsson R
Clin Pharmacol Ther; 2000 Sep; 68(3):250-60. PubMed ID: 11014406
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of azlocillin in healthy subjects.
Leroy A; Humbert G; Fillastre JP
Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
Madden T; de Lima M; Thapar N; Nguyen J; Roberson S; Couriel D; Pierre B; Shpall EJ; Jones RB; Champlin RE; Andersson BS
Biol Blood Marrow Transplant; 2007 Jan; 13(1):56-64. PubMed ID: 17222753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
